CBER Software Submission Guidance FDA CDRH

“Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices”. This guidance went direct to final without an opportunity for industry comment. Based on this together with FDA’s Good Guidance Practices FDA believes it does not substantively change recommendations made in the prior version of this guidance. Click on the link provided for the full guidance.

This is a new revised guidance issued May 11, 2005 jointly by FDA’s CDRH and CBER to replace the now obsolete 1998 version of this guidance.

This guidance defines software to be submitted as part of a premarket submission to FDA (i.e., PMA, 510(k), IDE). As such it applies directly only to software that is part of a medical device or is a medical device itself. It is important to note there is a difference between what is required to include in a submission and what might be required upon request or during an FDA inspection. For products that use any off-the-shelf software refer to the companion guidance on what to include regarding OTS software in a submission. Note that one should always check to see if there is specific 510(k) guidance for that type of device you’re interested in. These device specific guidances often have sections on specific software requirements for that type of device that supplement or explain the more general requirements in this document.

A few points to note are:
– Determination of level of concern is elaborated differently then in the prior guidance and attempts to clarify the distinction between moderate LOC and minor LOC.
– Provides clarifications on requirements and design specification to be provided
– Has new sections on Special and Abbreviated 510(k)s
– This guidance also applies to CBER regulated Blood Establishment Computer Systems (BECS).
– The guidance has been shortened to focus on submission requirements and much of the heuristic information in the prior guidance and its appendices has been eliminated
– A paragraph on virus protection software indicates that is beyond the scope of this guidance document.
– AAMI SW68 Medical Device Software — Software life cycle process and ISO 14971 Medical Device Risk Management are both mentioned.

SoftwareCPR Training Courses:

Being Agile & Yet Compliant (Public)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.

Lead Instructor: Mike Russell

Next public offerings:

  • Americas: 11-13 February 2025
  • EU/Eastern Europe/Middle East/Africa/Atlantic/eastern South America: 18-20 February 2025
  • Southern Central Northeastern Pacific: 24-26 February 2025
Register using form at this link:     Agile Course Post Promo

 

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Call or email now to schedule a private, in-house class. The fall schedule is filling up!

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.